These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34767134)

  • 1. Optimal Medical Therapy as First-Line Therapy for Chronic Coronary Syndromes: Lessons from COURAGE, BARI 2D, FAME 2, and ISCHEMIA.
    Brown DL
    Cardiovasc Drugs Ther; 2022 Oct; 36(5):1039-1045. PubMed ID: 34767134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention.
    Holper EM; Addo T
    Coron Artery Dis; 2010 Nov; 21(7):397-401. PubMed ID: 20634692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials.
    Mancini GBJ; Boden WE; Brooks MM; Vlachos H; Chaitman BR; Frye R; Bittner V; Hartigan PM; Dagenais GR
    Atherosclerosis; 2018 Oct; 277():186-194. PubMed ID: 29861270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies in stable ischemic heart disease: lessons from the COURAGE and BARI-2D trials.
    Fernandez SF; Boden WE
    Curr Atheroscler Rep; 2010 Nov; 12(6):423-31. PubMed ID: 20845088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous coronary intervention from COURAGE to ISCHEMIA and beyond.
    Weintraub WS; Mancini GBJ; Boden WE
    Int J Cardiol; 2023 Feb; 373():39-43. PubMed ID: 36427605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revascularization options in stable coronary artery disease: it is not how to revascularize, it is whether and when to revascularize.
    Torosoff MT; Sidhu MS; Desai KP; Fein SA; Boden WE
    J Comp Eff Res; 2015 Sep; 4(5):505-14. PubMed ID: 26387530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Death and Myocardial Infarction Following Initial Revascularization Versus Optimal Medical Therapy in Chronic Coronary Syndromes With Myocardial Ischemia: A Systematic Review and Meta-Analysis of Contemporary Randomized Controlled Trials.
    Soares A; Boden WE; Hueb W; Brooks MM; Vlachos HEA; O'Fee K; Hardi A; Brown DL
    J Am Heart Assoc; 2021 Jan; 10(2):e019114. PubMed ID: 33442990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention.
    Borden WB; Redberg RF; Mushlin AI; Dai D; Kaltenbach LA; Spertus JA
    JAMA; 2011 May; 305(18):1882-9. PubMed ID: 21558519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.
    Maron DJ; Spertus JA; Mancini GB; Hartigan PM; Sedlis SP; Bates ER; Kostuk WJ; Dada M; Berman DS; Shaw LJ; Chaitman BR; Teo KK; O'Rourke RA; Weintraub WS; Boden WE;
    Am J Cardiol; 2009 Oct; 104(8):1055-62. PubMed ID: 19801024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of optimal medical therapy and percutaneous coronary intervention on patients with stable angina.
    Latib A; Chieffo A; Colombo A
    Nat Clin Pract Cardiovasc Med; 2009 Feb; 6(2):92-3. PubMed ID: 19065124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interpreting the results of the COURAGE trial: a non-interventionalist perspective.
    Boden WE
    Rev Cardiovasc Med; 2009; 10 Suppl 2():S34-44. PubMed ID: 19898280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application and clinical implications of revascularization on chronic coronary syndromes: From COURAGE to ISCHEMIA trial.
    Tsigkas G; Moulias A; Xaplanteris P; Bousoula E; Tzikas S; Toutouzas K; Davlouros P
    Hellenic J Cardiol; 2021; 62(6):447-451. PubMed ID: 33176210
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical implications of the BARI 2D and COURAGE trials: overview.
    Brooks MM; Boden WE; Frye RL
    Coron Artery Dis; 2010 Nov; 21(7):383-5. PubMed ID: 20664331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic strategies in patients with chronic stable coronary artery disease.
    Zellweger MJ; Pfisterer ME
    Cardiovasc Ther; 2011 Dec; 29(6):e23-30. PubMed ID: 20491783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.
    Spertus JA; Maron DJ; Cohen DJ; Kolm P; Hartigan P; Weintraub WS; Berman DS; Teo KK; Shaw LJ; Sedlis SP; Knudtson M; Aslan M; Dada M; Boden WE; Mancini GB;
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):409-18. PubMed ID: 23838107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health status and quality of life in patients with stable coronary artery disease and chronic kidney disease treated with optimal medical therapy or percutaneous coronary intervention (post hoc findings from the COURAGE trial).
    Sedlis SP; Jurkovitz CT; Hartigan PM; Kolm P; Goldfarb DS; Lorin JD; Dada M; Maron DJ; Spertus JA; Mancini GB; Teo KK; Boden WE; Weintraub WS;
    Am J Cardiol; 2013 Dec; 112(11):1703-8. PubMed ID: 24011740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical Therapy Versus Revascularization in Patients with Stable Ischemic Heart Disease and Advanced Chronic Kidney Disease.
    Paul TK; Mamas MA; Shanmugasundaram M; Nagarajarao HS; Ojha CP; Jneid H; Kumar G; White CJ
    Curr Cardiol Rep; 2021 Mar; 23(4):23. PubMed ID: 33655382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes).
    Tamis-Holland JE; Lu J; Korytkowski M; Magee M; Rogers WJ; Lopes N; Mighton L; Jacobs AK;
    J Am Coll Cardiol; 2013 Apr; 61(17):1767-76. PubMed ID: 23500245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable coronary artery disease - medical treatment.
    Dąbrowski R; Dobrowolski M
    Pol Merkur Lekarski; 2017 Nov; 43(257):228-231. PubMed ID: 29231917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of myocardial ischemia on myocardial revascularization in stable ischemic heart disease. Lessons from the COURAGE and FAME 2 trials.
    Torosoff MT; Sidhu MS; Boden WE
    Herz; 2013 Jun; 38(4):382-6. PubMed ID: 23695652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.